Strut HealthPartner
Your shortlist for energy
By Peptide Clarity Guide · October 2026
Compare services that list NAD+ and related treatments: clinician access, pharmacy information, recurring costs and cancellation terms. Inclusion describes the service criteria; it does not establish that a treatment improves energy. Persistent fatigue deserves medical evaluation before choosing a wellness product.
All the energy providers, In first, then Not yet.
We may earn a commission through qualifying provider links at no extra cost to you. Read our selection criteria and funding disclosure. How we earn
Partners on this list
Partner cards: if you join through one, the provider pays us a fee and your price stays the same. The full list below keeps its pick order.
- NAD+ injections$151.07/mo
Made the shortlist
Listed in pick order. See how picks work.
Top pick NAD+ as a nasal spray, face cream, patch or shot, each with its own plan.
NAD+ cream$95/moVisit AgelessRxNAD+ injection has a published twenty-eight-day plan, distinct from calendar billing.
NAD+ injections$216.18/moVisit Goldspan HealthNAD+ as an injection or a nasal spray, priced inside a short intake.
NAD+ injectionsPrice on requestVisit Prime Doctor RXSeparate NAD+ injection and nasal plans show their selected recurring charges.
NAD+ nasal spray$134/moVisit HealthRXNAD+ has separate introductory and ongoing monthly program prices.
NAD+ injections$149/moVisit Precision TelemedStrut HealthPartner
NAD+ vial offers with 30-day renewal terms, with physician check-ins in the price.
NAD+ injections$151.07/moVisit Strut HealthNAD+ offers differ by route and bottle size, with a required processing fee.
NAD+ nasal spray$153.92/moVisit TeleZen MDNAD+ as an injection, oral drops or a nasal spray, all at one 4-week price.
NAD+ injections$216.18/moVisit Luvo HealthNAD+ as an injection or a daily troche, with no membership fee to join.
NAD+ injections$249/moVisit PauseRxNAD+ shots at one month-to-month price that covers the visit, follow-up and shipping.
NAD+ injections$129/moVisit BrightmedsGala GLP-1Partner
NAD+ has a stated written-review pathway; confirm the full charge schedule.
NAD+ injectionsPrice on requestVisit Gala GLP-1NAD+ has separate injection, nasal and oral listings; confirm the exact charge schedule.
NAD+ injectionsPrice on requestVisit LttlNAD+ injection has a starting monthly offer; it does not establish energy benefits.
NAD+ injections$199/moVisit Willow
Not a pick yet
Arc-1 Not yet
Why: Prints no cancellation terms for its monthly subscriptions.
When the gap closes, Arc-1 can move to In.
Read the pickBayan Health Not yet
Why: Investigational peptide listings leave the qualifying access pathway unclear.
When the gap closes, Bayan Health can move to In.
Read the pickBioGlow Health Not yet
Why: Approximate month-supply prices do not establish automatic refill charges or dates.
When the gap closes, BioGlow Health can move to In.
Read the pickbmiMD Not yet
Why: Terms describe twenty-eight-to-thirty-day renewal and separate quarterly billing.
When the gap closes, bmiMD can move to In.
Read the pickBodybuilding Health+ Not yet
Why: Lists Strive Pharmacy but not which Strive site fills your order.
When the gap closes, Bodybuilding Health+ can move to In.
Read the pickDirectMeds Not yet
Why: Its BPC-157 listing does not meet the reviewed routine commercial compounding conditions.
When the gap closes, DirectMeds can move to In.
Read the pickEden Not yet
Why: GLP-1 no-membership claims differ from recurring-membership terms.
When the gap closes, Eden can move to In.
Read the pickEdgeRx Not yet
Why: Names Strive Pharmacy as its one pharmacy, but not which Strive site ships.
When the gap closes, EdgeRx can move to In.
Read the pickElitePhysiqMD Not yet
Why: Its investigational peptide catalog leaves the qualifying access pathway unclear.
When the gap closes, ElitePhysiqMD can move to In.
Read the pickElleS Not yet
Why: The actual dispensing site and selected payment and refund agreement need confirmation.
When the gap closes, ElleS can move to In.
Read the pickEmbody Not yet
Why: Confirm the current renewal amount and charge interval before comparing plans.
When the gap closes, Embody can move to In.
Read the pickEnhance MD Not yet
Why: Its partner lists differ; confirm the actual dispensing pharmacy and site.
When the gap closes, Enhance MD can move to In.
Read the pickFridays Not yet
Why: TRT medication is extra; GLP-1 promotional totals need a selected renewal quote.
When the gap closes, Fridays can move to In.
Read the pickKIN Meds Not yet
Why: Starting hormone offers do not settle the selected form, testing and recurring total.
When the gap closes, KIN Meds can move to In.
Read the pickLive Vital Not yet
Why: Its peptide menu does not meet the reviewed routine commercial compounding conditions.
When the gap closes, Live Vital can move to In.
Read the pickMangoRx Not yet
Why: The TRT testing offer and laboratory costs leave the full medication renewal unclear.
When the gap closes, MangoRx can move to In.
Read the pickNext Vial Not yet
Why: Starting offers and differing GLP-1 pages leave selected renewal charges unconfirmed.
When the gap closes, Next Vial can move to In.
Read the pickNova Not yet
Why: Prescribing-decline fees and medication and membership charges need clarification.
When the gap closes, Nova can move to In.
Read the pickOak Not yet
Why: Lists tesamorelin without saying whether it's the brand drug or compounded.
When the gap closes, Oak can move to In.
Read the pickPeterMD Not yet
Why: Confirm the dispensing facility, current authorization and actual recurring agreement.
When the gap closes, PeterMD can move to In.
Read the pickRNK Health Not yet
Why: Inclusive-price claims differ from terms allowing separate pharmacy fees.
When the gap closes, RNK Health can move to In.
Read the pickScience & Co Not yet
Why: Annual headlines do not establish the selected ongoing invoice and charge interval.
When the gap closes, Science & Co can move to In.
Read the pickSkinnyRx Not yet
Why: Current introductory GLP-1 offers do not establish the later renewal charge.
When the gap closes, SkinnyRx can move to In.
Read the pickSprout Health Not yet
Why: Four-week product renewal differs from monthly policy and legacy payment instructions.
When the gap closes, Sprout Health can move to In.
Read the pickSystem Labs Not yet
Why: Homepage and product offers differ; crossed-out figures do not establish renewal.
When the gap closes, System Labs can move to In.
Read the pickWellorithm Not yet
Why: Monthly pricing and twenty-eight-day terms describe different renewal schedules.
When the gap closes, Wellorithm can move to In.
Read the pickWePeptideRx Not yet
Why: Dose-selector prices differ from the same product page’s overview.
When the gap closes, WePeptideRx can move to In.
Read the pick
What the rules check, and what to expect
Getting In takes six things. Someone licensed reads your intake before a vial ships. You see the monthly cost before you type a card number. A licensed US pharmacy does the compounding, and the store sells no research-use peptides. Cancel terms are posted, and the signup really opens. How picks work has the exact wording.
Now the honest part. NAD+ participates in cellular energy metabolism, but that mechanism does not establish a benefit from an injected product. FDA’s interim compounding policy is conditional. No controlled wellness evidence establishing improved energy from these home injections was identified. Start with what NAD+ is, then how long NAD+ shots take to work and at-home shots versus an IV drip.
How to choose between the picks
- Start with the fatigue assessment. Tell the clinician when the tiredness began and how it affects ordinary activities. Ask whether the assessment investigates that complaint or simply screens eligibility for a wellness prescription. Those are different services even when both use an online questionnaire. Establish what findings would lead to another evaluation instead of an NAD+ order. A treatment menu cannot identify the cause of your fatigue.
- Ask what the proposed route actually demonstrates. An IV study, a home injection and a nasal preparation involve different exposure questions. A blood marker moving in one setting does not establish that another formulation improves daily energy. Request the study population and measured outcome behind the proposed claim. Also ask whether the preparation offered to you matches that research. Convenience can inform a preference without proving equivalent benefit.
- Translate the vial offer into your invoice. Record the prescribed quantity, shipment frequency and amount collected at renewal. A vial described as a month of supply does not establish when another payment will occur. Include any consultation or membership that continues between shipments. The calculator can annualize a confirmed fixed-day charge using a 365-day basis. Actual payments during your enrollment depend on their dates and your stopping point.
- Agree on a meaningful reassessment. Ask which change in daily functioning would justify continuing the proposed care. A testimonial or a laboratory marker alone cannot establish that your fatigue improved because of NAD+. Clarify when the clinician will revisit the decision and what happens if you notice no benefit. Find out whether that conversation is included or separately charged. Buying a longer supply should not replace the reassessment.
Questions about this list
- How much does NAD+ cost a month?
- Selected current examples include Brightmeds at $129 monthly and HealthRX at $161 for a one-month injection plan. Confirm prescribed quantity and included services; the cost guide separates vial and prepaid offers.
- Will NAD+ injections give me more energy?
- Nobody can promise that. Controlled evidence has not established improved energy from the commercial at-home NAD+ injections. Testimonials cannot establish benefit. Discuss the cause of fatigue, alternatives and meaningful monitoring with your clinician.
- Why do glutathione and sermorelin count toward the energy list?
- People hunting for more energy ask about both, so a provider that sells either one can appear here. NAD+ is still the main reason this list exists, and each compound has its own guide on what the studies show.
- Is NAD+ FDA-approved?
- No. Injectable NAD+ is a compounded prescription. FDA’s Category 1 listing is under evaluation and its interim policy has conditions. A prescription and pharmacy license do not by themselves approve a finished preparation.
This is general information, not medical advice. A licensed clinician can tell you what fits you. Health note